Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Early Interv Psychiatry. 2019 Jul 2;14(2):211–219. doi: 10.1111/eip.12848

Table 2.

Within and Between Period Changes in Anxiety, Emotion Regulation, Mindfulness and Clinical Severity in the Waitlist and Treatment Periods

Variable Baseline MSD) Endpoint MSD) Within period p-value Within period effect size Between period change (95% CI) Between period effect size Between period p-value
Clinician-rated anxiety (PARS)
 Waitlist 12.1±4.5 9.6±4.4 0.12 −.23 −1.6 (−7.3, 4.0) −0.08 0.56
 MBCT-C 9.6±4.4 5.6±5.7 0.01 −.36
Child-rated state anxiety (STAI)
 Waitlist 34.4±7.1 34.1±6.9 0.89 −.02 0.7 (−7.2, 8.6) 0.03 0.86
 MBCT-C 34.1±6.9 34.6±9.0 0.87 .02
Child-rated trait anxiety (STAI)
 Waitlist 40.8±9.7 37.8±10.2 0.10 −.62 −2.7 (−8.4, 2.9) −0.36 0.32
 MBCT-C 37.8±10.2 31.2±10.2 <0.01 −1.19
Emotional lability (ERC)
 Waitlist 31.8±6.2 29.7±6.6 0.45 −.17 −0.9 (−7.8, 6.1) −0.06 0.81
 MBCT-C 29.7±6.6 28.5±6.1 0.34 −.22
Emotion regulation (ERC)
 Waitlist 23.8±4.7 24.3±4.6 0.61 .12 −1.0 (−6.0, 4.0) −0.09 0.69
 MBCT-C 24.3±4.6 23.8±5.3 0.85 −.04
Mindfulness (CAMM)
 Waitlist 20.9±9.9 24.6±9.0 <0.01 .58 −1.9 (−7.9, 4.1) −0.13 0.54
 MBCT-C 24.6±9.0 27.2±10.1 0.39 .19
Clinical global severity (CGI-S)
 Waitlist 3.3±.8.0 3.4±1.0 0.92 −.01 −1.0 (−2.1, 0.0) −0.29 0.05
 MBCT-C 3.4±1.0 2.3±1.2 <0.01 −.44

Note.

Endpoint in the waitlist period = baseline in the MBCT-C period.

MBCT-C (week 12 - week 0) - Waitlist (week 12- week 0); negative values indicate greater reductions in MBCT-C period as compared to the Waitlist period. PARS: Pediatric Anxiety Rating Scale; STAI: State-Trait Anxiety Inventory; ERC: Emotion Regulation Checklist; CAMM: Child and Adolescent Mindfulness Measure; CGI-S: Clinical Global Impression-Severity.